当前位置：首页 > 文献互助 > 互助详情

Durvalumab in Combination With Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: Long-Term Analysis From the GeparNuevo Trial复制

用户EO9nReo4Hj6s 34分钟前 15 10 已完结

1. 当前求助状态已完结, 请及时下载应助文件

2. 系统将在 2026-09-15 17:00:55 删除文件

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1200/jco-25-02311复制

文献链接: https://ascopubs.org/doi/10.1200/JCO-25-02311复制

其他信息:

出版社: American Society of Clinical Oncology (ASCO)
作者: Sibylle Loibl; Michael Untch; Jens Huober; Vanessa Schaser; Michael Braun; Carsten Denkert; Andreas Hartkopf; Jens-Uwe Blohmer; Claus Hanusch; Theresa Link; Mattea Reinisch; Dirk-Michael Zahm; Rudolf Weide; Vesna Bjelic-Radisic; Peter Staib; Hans Tesch; Kerstin Rhiem; Ralf Lorenz; Julia Rey; Andreas Schneeweiss

上一篇：Neoadjuvant Durvalumab ± Tremelimumab in Combination With Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Carcinoma: Results of the Phase I/II NEMIO Study

下一篇：CALYPSO: Final Results of Savolitinib and Durvalumab Combination in Metastatic Papillary Renal Cancer

互助时间线

2026-09-08 17:04:15 [完结求助]

楼主确认了自然之声应助的文件是正确的, 求助状态变成 已完结

2026-09-08 17:00:55 [上传文件]

自然之声上传了文件(pdf 322.53 KB), 求助状态变成 待确认

2026-09-08 16:41:42 [发起求助]

最新发布的求助

Dapagliflozin as an Adjunct to Insulin Improves Time-in-Range and Glycemic Variability versus Acarbose in Adults With Type 1 Diabetes: A Randomized Crossover Trial 9分钟前
https://doi.org/10.1063/1.3499306 27分钟前
Addition of ipilimumab to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma (PRODIGE 81-FFCD 2101-TRIPLET HCC): phase 2 results from a randomised, multicentre, open-label, phase 2–3 trial 27分钟前
On-demand transarterial chemoembolisation combined with atezolizumab and bevacizumab in patients with untreated hepatocellular carcinoma (TALENTACE): a multicentre, randomised, open-label, phase 3 trial 29分钟前
Redox‐Neutral Vicinal Dialkylation of Aryl Boronic Esters via the Palladium/Norbornene Cooperative Catalysis 31分钟前
CALYPSO: Final Results of Savolitinib and Durvalumab Combination in Metastatic Papillary Renal Cancer 33分钟前
Durvalumab in Combination With Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: Long-Term Analysis From the GeparNuevo Trial 34分钟前
Neoadjuvant Durvalumab ± Tremelimumab in Combination With Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Carcinoma: Results of the Phase I/II NEMIO Study 35分钟前
New and Practical Synthesis of N-(Pyrimidin-5-ylmethyl)pyridin-2-amine, the Key Intermediate to Triflumezopyrim 37分钟前
6PPD-Q: A comprehensive critical review on environmental occurrence, toxicological mechanisms, risk assessment, and mitigating strategies 55分钟前
Tire-derived antioxidants in terrestrial ecosystems: Occurrence, mechanistic toxicity, and sustainable mitigation strategies 1小时前
Ecotoxicity of 6PPD and 6PPD-Q in aquatic ecosystems: Mechanisms, influencing factors, and mitigation strategies 1小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com